Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

1.

Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.

Li W, Zhai L, Tang Y, Cai J, Liu M, Zhang J.

Oncol Res. 2012;20(2-3):49-59.

PMID:
23193911
[PubMed - indexed for MEDLINE]
2.

Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.

Li W, Tang YX, Wan L, Cai JH, Zhang J.

Oncol Lett. 2013 Mar;5(3):923-928. Epub 2012 Dec 19.

PMID:
23426648
[PubMed]
Free PMC Article
3.

Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.

Wang L, Chen W, Xie X, He Y, Bai X.

Exp Oncol. 2008 Mar;30(1):42-51.

PMID:
18438340
[PubMed - indexed for MEDLINE]
4.

Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.

Li W, Liu ML, Cai JH, Tang YX, Zhai LY, Zhang J.

Oncol Lett. 2012 Jul;4(1):168-174. Epub 2012 Apr 23.

PMID:
22807982
[PubMed]
Free PMC Article
5.

Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin d1 and ki-67 in a xenograft model of ovarian carcinoma.

Li W, Cai JH, Zhang J, Tang YX, Wan L.

Int J Mol Sci. 2012;13(8):9741-53. doi: 10.3390/ijms13089741. Epub 2012 Aug 3.

PMID:
22949827
[PubMed]
Free PMC Article
6.

Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.

Li W, Xu RJ, Lin ZY, Zhuo GC, Zhang HH.

Med Oncol. 2009;26(2):170-7. doi: 10.1007/s12032-008-9104-9. Epub 2008 Nov 6.

PMID:
18988002
[PubMed - indexed for MEDLINE]
7.

Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.

Li W, Wang J, Jiang HR, Xu XL, Zhang J, Liu ML, Zhai LY.

Int J Mol Sci. 2011 Jan 18;12(1):668-81. doi: 10.3390/ijms12010668.

PMID:
21340007
[PubMed - in process]
Free PMC Article
8.

Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.

Li W, Zhang HH, Xu RJ, Zhuo GC, Hu YQ, Li J.

Med Oncol. 2008;25(2):172-7. doi: 10.1007/s12032-007-9016-0. Epub 2007 Oct 6.

PMID:
18488158
[PubMed - indexed for MEDLINE]
9.
10.

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.

Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T, Ohta T.

Oncol Rep. 2012 Sep;28(3):777-84. doi: 10.3892/or.2012.1885. Epub 2012 Jun 26.

PMID:
22751903
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.

Li W, Ji ZL, Zhuo GC, Xu RJ, Wang J, Jiang HR.

Med Oncol. 2010 Mar;27(1):98-104. doi: 10.1007/s12032-009-9179-y. Epub 2009 Feb 24.

PMID:
19235530
[PubMed - indexed for MEDLINE]
12.

Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.

Quidville V, Segond N, Tebbi A, Cohen R, Jullienne A, Lepoivre M, Lausson S.

Thyroid. 2009 Jun;19(6):613-21. doi: 10.1089/thy.2008.0194.

PMID:
19281427
[PubMed - indexed for MEDLINE]
13.

Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.

Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X.

Cancer Prev Res (Phila). 2010 Jun;3(6):787-96. doi: 10.1158/1940-6207.CAPR-09-0243. Epub 2010 May 25.

PMID:
20501859
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].

Gao J, Li JS, Xu GL, Jia WD, Ma JL, Yu JH, Ge YS.

Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):900-4. doi: 10.3760/cma.j.issn.1007-3418.2010.12.005. Chinese.

PMID:
21205474
[PubMed - indexed for MEDLINE]
15.

[Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].

Ran JT, Zhou YN, Tang CW, Lu JR, Wu J, Lu H, Yang GD.

Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):448-51. Chinese.

PMID:
19024521
[PubMed - indexed for MEDLINE]
16.

Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.

Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT.

Cancer. 2007 Feb 1;109(3):588-97.

PMID:
17177201
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.

Park W, Oh YT, Han JH, Pyo H.

J Exp Clin Cancer Res. 2008 Nov 11;27:66. doi: 10.1186/1756-9966-27-66.

PMID:
19000324
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.

Rao CV, Steele VE, Swamy MV, Patlolla JM, Guruswamy S, Kopelovich L.

Cancer Res. 2009 Oct 15;69(20):8175-82. doi: 10.1158/0008-5472.CAN-09-1377. Epub 2009 Oct 13.

PMID:
19826045
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.

Kaneko M, Kaneko S, Suzuki K.

Cancer Sci. 2009 Nov;100(11):2193-201. doi: 10.1111/j.1349-7006.2009.01280.x. Epub 2009 Jul 8.

PMID:
19673886
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk